Acasti Pharma Inc. held its Annual Meeting of Shareholders on October 10, 2023 and the following nominees were elected as directors A. Brian Davis, S. George Kottayil, Prashant Kohli and Edward Neugeboren.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | -0.97% | +1.05% | +0.35% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.35% | 27.26M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Acasti Pharma Inc. Announces Board Changes